Transitional Drugs 7
| Source: | Find a Tender Service (FTS) |
| Buyer: | NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) |
| Main Category: | Goods |
| Procurement Method: | — |
| Tender Status: | Planning |
| Estimated Value (ex. VAT): | £53,566,932 |
| Estimated Value (inc. VAT): | £64,280,318 |
| Release Date: | 8 April 2026 |
| Application Deadline: | 9 April 2026 |
| Contract Start Date: | 30 June 2026 (Estimated) |
| Contract End Date: | 30 June 2028 (Estimated) |
| Contract Duration: | 2.0 years |
| Procurement ID (OCID): | ocds-h6vhtk-067da4🔒 BidWriter |
| Notice Reference: | 031798-2026🔒 BidWriter |
Ready to bid on this contract?
BidWriter AI writes your tender response in minutes — import this contract in one click.
View Original Notice
Access the full notice on the official portal
Description
This is a contract for the provision of Drugs that have recently lost patent - Eculizumab, Tocilizumab, Nintedanib and Omalizumab
Links & Documents
Apply Online
Proceed to the official portal to submit your bid.
Similar contracts
Transitional Drugs 7
NHS Wales Shared Services Partnership - Procurement Services (hosted by Velindre NHS Trust) · WAC-581319
RELATIONAL CARE TRAINING - HDDA-ITT-62670 (P0453)
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · WAC-580480
TRN744-03-2026 BI Services Support
North Sea Transition Authority · WAC-580781
Pipeline status
Not addedContract imported automatically · AI writes the response
Assign to team member
Delegate this bid in BidWriter
Run Bid / No Bid analysis
Score this opportunity in BidWriter
Sign in to BidWriter to sync favourites across devices
Application Deadline
9 April 2026
Closed
Estimated Value
£53,566,932
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →